Sign in

CIK 0001563880

  • Non-accelerated filer
  • Smaller reporting company

Trevi Therapeutics, Inc.

Sign in to watch
Ticker
TRVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450834299
Phone
+1 203-304-2499
Business address
195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$595,806
in 1 filing, $596K under 10b5-1 plans

Net −$595,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Heffernan Michael Thomas −$596K Director sold 86% of stake

Reading 6 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-19 Simon Farrell Chief Commercial Officer Grant or award · Stock Option (right to buy) +160,000 160,000
2025-05-31 Simon Farrell Chief Commercial Officer Grant or award · Performance Stock Option (right to buy) +72,000 110,400
2025-03-10 Simon Farrell Chief Commercial Officer Exercise or conversion 10b5-1 +17,500 $3.21 $56K 63,150
2025-03-10 Simon Farrell Chief Commercial Officer Exercise or conversion 10b5-1 +63,813 $3.91 $250K 126,963
2025-03-10 Simon Farrell Chief Commercial Officer Exercise or conversion 10b5-1 +31,250 $0.51 $16K 158,213
2025-03-10 Simon Farrell Chief Commercial Officer Sale 10b5-1 −76,963 $6.73 $518K 81,250
2025-03-10 Simon Farrell Chief Commercial Officer Sale 10b5-1 −4,350 $7.15 $31K 76,900
2025-03-10 Simon Farrell Chief Commercial Officer Grant or award · Performance Stock Option (right to buy) 10b5-1 +38,400 38,400
2025-03-10 Simon Farrell Chief Commercial Officer Exercise or conversion · Performance Stock Option (right to buy) 10b5-1 −17,500 0
2025-03-10 Simon Farrell Chief Commercial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −63,813 11,187
2025-03-10 Simon Farrell Chief Commercial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −31,250 18,750
2025-02-18 Simon Farrell Chief Commercial Officer Grant or award · Stock Option (right to buy) +225,500 225,500
2024-02-15 Simon Farrell Chief Commercial Officer Grant or award · Stock Option (right to buy) +175,000 175,000
2023-06-20 Simon Farrell Chief Commercial Officer Exercise or conversion +6,250 $0.51 $3K 45,650
2023-06-20 Simon Farrell Chief Commercial Officer Exercise or conversion · Stock Option (right to buy) −6,250 50,000
2023-03-07 Simon Farrell Chief Commercial Officer Exercise or conversion +18,750 $0.51 $10K 39,400
2023-03-07 Simon Farrell Chief Commercial Officer Exercise or conversion · Stock Option (right to buy) −18,750 56,250
2023-02-16 Simon Farrell Chief Commercial Officer Grant or award · Stock Option (right to buy) +100,000 100,000

Page 1 of 1 · 18 trades